Background {#Sec1}
==========

Foreign Body Aspiration (FBA) is a serious common problem in children. Any delay in its diagnosis and management can result in devastating consequences \[[@CR1]--[@CR3]\]. FBA is quoted as the fifth cause of unintentional death among 1--3 year olds and the primary cause of unintentional death in babies under 12 months \[[@CR4]\]. Physicians often struggle with the all too important, yet elusive, decision-"To bronch, or not to bronch" patients who present with suspected FBA. In most cases, the history is often vague, with only subtle (if any), physical and chest radiological abnormalities \[[@CR5]--[@CR10]\]. With this study, we aim to use our local experience in Qatar to retrospectively analyze bronchoscopically proven cases of FBA in an attempt to determine the statistically significant key clinical predictors of foreign body aspiration in children, based on the patient's historical, physical and radiological findings at presentation.

Methods {#Sec2}
=======

Study design and participants {#Sec3}
-----------------------------

This is a retrospective observational study, including all patients aged 0 to 14 years, who were admitted to the pediatric department of Hamad Medical Corporation, Qatar between January 2001 to January 2011 with suspected FBA. We analyzed only patients who were exclusively admitted to the pediatric ward with a diagnosis of suspected FBA. Patients who underwent a bronchoscopy for other indications or required a bronchoscopy to exclude FBA later in the course of their illness, but were not admitted with a diagnosis of suspected FBA, were excluded. This study was approved by the research and ethics committee of the Hamad Medical Corporation (RC 11099/11).

Study measures and data variables {#Sec4}
---------------------------------

The charts of the patients who met the eligibility criteria were retrospectively reviewed in detail. The history, presenting symptoms, clinical assessments as documented by the admitting pediatrician at the time were collected. Most of the patients (242, 80.7%) had an electronic record of the chest x-ray (CXR) that was read by the radiologist at the time of admission. These were noted and analyzed.

All 300 of these patients underwent at least one bronchoscopy, either flexible or rigid or both, depending upon their presentation. Generally, if there was a very definite history of witnessed choking and the patient presented with significant physical examination findings such as stridor, reduced air entry, hypoxia, tachypnea or obvious CXR abnormalities like radio-opaque FB, mediastinal shift, unilateral atelectasis/hyperinflation or a combination of any of these, the patient was referred directly to the pediatric surgical team who then proceeded for urgent rigid bronchoscopy under general anesthesia. If the patient presented with more subtle/less apparent radiological or physical examination findings, the pediatric pulmonology team was consulted to consider a flexible bronchoscopy as the initial procedure of choice. This trend of selecting rigid versus flexible bronchoscopy, based on the patients' initial presentation, remained unchanged in the years pertaining to our study.

The bronchoscopy records were reviewed for details like type (flexible versus rigid), size of bronchoscope and instrumentation used for foreign body (FB) extraction, outcomes including presence, type and location of FB and pre- and post- procedure complications.

Statistical analysis {#Sec5}
--------------------

The focus of the data analysis in our study was to determine the predictive accuracy of the various predictors and covariates in diagnosing FBA. For this, the sensitivity, specificity, positive and negative predictive values of these parameters were calculated, using bronchoscopy diagnosis of FBA as the point of reference. A receiver operating characteristic (ROC) curve was calculated using significant predictors (as determined via multivariate regression) to derive best suitable cut-off values and to assess model discrimination and predictive accuracy. ROC curves provide a comprehensive and visually attractive way to summarize the accuracy of predictions. The ROC curve shows the tradeoff between sensitivity and specificity and is a better method to detect the performance of a developed test, which classifies subjects into two categories such as FBA positive and FBA negative.

Associations between two or more qualitative variables were assessed using chi-square test and Fisher Exact test as appropriate. Univariate and multivariate logistic regression methods were used to assess the predictive values of each predictor or risk factors (clinical signs and symptoms, physical exam and radiological findings) for bronchoscopy proven FBA. For multivariate regression models, variables were considered if statistically significant at the *P* \< 0.10 level in univariate analysis or if determined to be clinically important. The results of logistic regression analyses were reported as odds ratio (OR) with 95% confidence intervals (CIs). The number of risk factors identified in multivariable logistic regression analyses were summarized to compute weighted risk score and generate a clinically applicable and decision making rule for the prediction of FBA. To derive a simple-to-compute risk score, the regression coefficients were divided by the smallest coefficient and then rounded to the nearest integer. Pictorial presentations of the key results were made using appropriate statistical graphs. A two-sided *P* value \<0.05 was considered to be statistically significant. All statistical analyses were done using statistical packages SPSS 22.0 (SPSS Inc. Chicago, IL) and Epi Info 2000 (Centers for Disease Control and Prevention, Atlanta, GA).

Results {#Sec6}
=======

Patient characteristics {#Sec7}
-----------------------

Based on the inclusion criteria, a total of 300 children were included in this study. Of the 300 patients, 163 were boys (54.3%) and 137 were girls (45.7%), giving a male-to-female ratio of 1.2:1. A total of 139 children (46.3%) were Qatari nationals. The mean age was 2.1 ± 1.7 years (range 7 months to 14 years) with a peak incidence at 1 to 2 years of age. Seventy patients (23.3%) were less than 12 months of age.

These 300 patients cumulatively underwent a total of 410 bronchoscopies, which included both flexible and rigid bronchoscopies (88 patients underwent 2 bronchoscopies, 17 had 3, 4 patients had 4 and one patient underwent 5 bronchoscopies). Only 190 (66.7%) had a definite history of FBA. FB was found in the airway in 91 of the 300 children (30.3%). In all of these children, the FB was successfully extracted. The demographic characteristics, clinical, laboratory and bronchoscopy findings of the study population are shown in Table [1](#Tab1){ref-type="table"}.Table 1Demographic characteristics, clinical, laboratory and bronchoscopy findingsCharacteristicsNFrequency (%)Gender Male\
 Female300163 (54.3)\
137 (45.7)Nationality Qatari\
 Non-Qatari300139 (46.3)\
161 (53.7)Age (years) \< 1 year\
 1 to \<2 year\
 2 to \< 3 year\
 3 to \< 4 year\
 4 to \<7 year\
 7--14 year30070 (23.3)\
122 (40.7)\
37 (12.3)\
26 (8.7)\
27 (9)\
18 (6)Bronchoscopy Episode One\
 Two\
 Three\
 Four\
 Five410300 (73.2)\
88 (21.5)\
17 (4.1)\
4 (1)\
1 (0.2)Method of Bronchoscopy Flexible\
 Rigid410318 (77.6)\
92 (22.4)History of Foreign Body^a^ Definite\
 Suspected285190 (66.7)\
95 (33.3)Foreign Body Aspiration Foreign Body Present\
 No Foreign Body30091 (30.3)\
209 (69.7)Type of Foreign Body Organic\
 Non-organic\
 Type of FB not specified9157 (62.6)\
8 (8.8)\
26 (28.6)Organic Foreign Body Nuts\
 Seed\
 Bone\
 Others (not specified)5728\
13\
3\
13Inorganic Foreign Body Inorganic sharp object\
 Inorganic blunt object\
 Others (not specified)85\
2\
1Location and site of FB Right airways\
 Left airways\
 Trachea\
 Others9143 (47.3)\
32 (35.2)\
6 (6.6)\
10 (10.9)Route of Bronchoscopy Nasally\
 Orally\
 Through ETT410306 (74.6)\
93 (22.7)\
11 (2.7)Broncho-alvelolar lavage Yes\
 No30056 (18.7)\
244 (81.3)Bronchoalveolar culture findings Negative\
 Positive5636 (64.3)\
20 (35.7)Complications during procedure Transient hypoxia\
 Laryngospasm\
 Bronchospasm\
 Nose bleed\
 Bradycardia\
 Intubation\
 Others168 (2)\
1 (0.2)\
1 (0.2)\
1 (0.2)\
3 (0.7)\
1 (0.2)\
1 (0.2)Complications after procedure Excessive cough\
 Pneumonia\
 Stridor\
 Tachypnea\
 Tension Pneumothorax\
 Others83 (0.7)\
1 (0.2)\
1 (0.2)\
1 (0.2)\
1 (0.2)\
1 (0.2)*FBA* Foreign body aspiration^a^In 15 cases no documentation was present in their medical records regarding the history of FB

Clinical signs and symptoms {#Sec8}
---------------------------

Positive history of noisy breathing/stridor/dysphonia and recurrent/persistent wheezing were notably more common in children with FBA compared to children without FBA. There was no significant difference observed in the occurrence of other clinical signs and symptoms between the two groups (*P* \> 0.05) as shown in Table [2](#Tab2){ref-type="table"}. In children with bronchoscopically proven FBA, the two most common presenting symptoms were; cough in 79.1% and witnessed choking in 71.4%. However, both witnessed choking and cough had a low specificity i.e. 36 and 31.1% respectively (Tables [3](#Tab3){ref-type="table"} and [4](#Tab4){ref-type="table"}). Therefore, it can be concluded that the presence of either of these cannot be relied upon for an accurate diagnosis of FBA.Table 2Association of clinical sign and symptoms, physical and radiologic findings between children with recovery of a foreign body during bronchoscopy (FBA positive) and those without FBA (FBA negative) (univariate logistic regression analysis)FBA positiveFBA negativeUnadjusted odds ratio (95%CI)*P*-value\*Clinical signs and symptoms (*n* = 300) Witnessed choking65 (71.4%)134 (64.1%)1.39 (0.82, 2.39)0.219 Cough72 (79.1%)144 (68.9%)1.71 (0.95, 3.07)0.072 Noisy breathing/stridor/ dysphonia21 (23.1%)23 (11%)2.43 (1.26, 4.66)0.008 Dyspnea32 (35.2%)57 (27.3%)1.45 (0.85, 2.45)0.170 Cyanosis11 (12.1%)46 (22%)0.49 (0.24, 0.99)0.047 New onset wheezing/ recurrent/persistent wheeze20 (22%)14 (6.7%)3.92 (1.89, 8.18)0.0001 Recurrent and/or persistent respiratory infection/ recurrent pneumonia0 (0%)2 (1%)n.a0.999 Vomiting14 (15.4%)35 (16.7%)0.90 (0.46, 1.78)0.769 Fever21 (23.1%)37 (17.7%)1.40 (0.76, 2.55)0.280 Others8 (8.8%)26 (12.4%)0.68 (0.29, 1.56)0.362Radiological findings (*n* = 242) Abnormal63 (82.9%)87 (52.4%)4.40 (2.25, 8.60)0.0001 Unilateral hyperinflation right/left side31 (40.8%)34 (20.5%)2.68 (1.48, 4.84)0.001 Bilateral hyperinflation10 (13.2%)20 (12%)1.11 (0.49, 2.49)0.808 Right/left/bilateral infiltrates10 (13.2%)11 (6.6%)2.14 (0.87, 5.27)0.100 Radio-opaque FB4 (5.3%)0 (0%)0.009 Collapse/Consolidation6 (7.9%)11 (6.6%)1.21 (0.43, 3.40)0.720 Others2 (2.6%)7 (4.2%)0.61 (0.13, 3.03)0.549Physical examination findings (*n* = 290) Normal21 (23.3%)112 (56%)0.24 (0.14, 0.42)0.0001 Unilateral reduced entry Right/left side53 (58.9%)54 (27%)3.87 (2.30, 6.54)0.0001 Stridor1 (1.1%)3 (1.5%)0.74 (0.08, 7.19)0.794 Wheezing29 (32.2%)37 (18.5%)2.09 (1.19, 3.70)0.011 Bilateral reduced air entry2 (2.2%)11 (5%)0.43 (0.09, 2.01)0.285 Retractions9 (10%)15 (7.5%)1.37 (0.58, 3.26)0.476 Tachypnea5 (5.6%)3 (1.5%)3.86 (0.90, 16.53)0.068 Crackles12 (13.3%)21 (10.5%)1.31 (0.62, 2.80)0.483 Others4 (4.4%)3 (1.5%)3.05 (0.67, 13.94)0.149In 58 cases Chest-X-ray was not done/and or not reported and hence % computation was based on *n* = 242In 10 cases physical exam findings were not documented and thus % computation was based on *n* = 290*OR* odds ratio, *CI* confidence interval\*Pearson Chi-square and Fisher exact test, logistic regression analysis Table 3Multivariate logistic regression model for determining significant predictors and deriving risk score for FBAPredictor categoryPredictorFBA positiveFBA negativeRegression coefficientAdjusted odds ratio^a^ (95%CI)*P*-value\*Weight risk score^b^Clinical sign and symptomsWitnessed choking65 (71.4%)134 (64.1%)0.7532.12 (1.10, 4.38)0.0411Clinical sign and symptomsNoisy breathing/ Stridor/ Dysphonia21 (23.1%)23 (11%)1.012.74 (1.22, 6.17)0.0151Clinical sign and symptomsNew onset wheezing/ Recurrent/persistent wheeze20 (22%)14 (6.7%)1.524.57 (1.77, 11.76)0.0022RadiographicAbnormal Chest X-ray findings31 (40.8%)34 (20.5%)1.394.01 (1.88, 8.53)\<0.0012Physical examinationUnilateral reduced air entry21 (23.3%)112 (56%)1.072.90 (1.53, 5.52)0.0011*OR* odds ratio, *CI* confidence interval\*Pearson Chi-square and Fisher exact test^a^Adjusted for all other potential covariates found in the univariate logistic regression analysis^b^The scores were computed and derived by dividing the regression coefficients of the included predictors by the smallest regression coefficient and then rounding them to the nearest integer. For each patient, a sum score was calculated by adding the scores that correspond to the predictors and characteristics of the patient Table 4Diagnostic value of clinical sign and symptoms, radiological and physical exam findings with statistically significant predictors derived from logistic regression for proven foreign body aspirationSensitivity (%)Specificity (%)PPV (%)NPV (%)*P*-value\*Noisy breathing/stridor/dysphonia23.189.047.772.70.008Cyanosis12.178.019.367.10.047New onset wheezing/recurrent/persistent wheeze2293.358.873.30.0001Abnormal Chest-X-ray82.947.64285.90.0001Unilateral hyperinflation right/left side40.879.547.774.60.001Radio-opaque FB5.310010069.80.009Normal physical examination23.344.015.856.10.0001Unilateral reduced air entry right/left side32.281.543.972.80.011Wheezing58.973.049.579.80.0001*PPV* positive predictive value, *NPV* negative predictive value\*Pearson Chi-square and Fisher exact test

Physical exam findings {#Sec9}
----------------------

Decreased air entry (58.9% vs 27%; *P* = 0.0001) and wheezing (32.2% vs 18.5%; *P* = 0.011) were significantly more common in children with FBA compared to children without FBA. Children without FBA were also more likely to have a completely normal physical exam when compared to children with FBA (56% vs 23.3%; *P* = 0.0001). No statistically significant differences were observed in the frequencies of other related physical exam findings between children with FBA and those without FBA (*P* \> 0.05); refer to Table [2](#Tab2){ref-type="table"}.

Chest Radiographic (CXR) findings {#Sec10}
---------------------------------

Of the 91 children with bronchoscopically proven FBA, 13 (17.1%) had normal chest radiographs, 31 (40.8%) and 10 (13.2%) had unilateral and bilateral hyperinflation, respectively. Ten patients had either right/left or bilateral lung infiltrates, six patients (7.9%) had collapse-consolidation, and 4 (5.3%) had radio-opaque FB and 2 had other findings. In 15 cases the CXR was either not done or not reported. Of note, children in the FBA group were significantly less likely to have a normal CXR compared to children without FBA (*P* \< 0.0001). There were no significant differences observed in the occurrence of other radiological findings between the two groups (*P* \> 0.05) as shown in Table [2](#Tab2){ref-type="table"}, apart from the finding of a radio-opaque FB, which had a specificity and positive predictive value of 100% (Tables [3](#Tab3){ref-type="table"} and [4](#Tab4){ref-type="table"}).

Bronchoscopy findings {#Sec11}
---------------------

As stated previously, 91 (30.3%) of the 300 patients had a bronchoscopically confirmed diagnosis of FBA. In all of these cases, the FB was successfully removed; in 67 cases (74.4%) with rigid bronchoscopy and in 23 patients (25.6%) using a flexible bronchoscope. One patient required a thoracotomy. The flexible bronchoscopy was conducted by an experienced pediatric pulmonologist in most cases via the nasal route under moderate sedation in an intensive care setting. In 6 patients, it was performed in the operating theatre through an endotracheal tube under general anesthesia with a surgeon on standby. On the other hand, rigid bronchoscopies were performed by pediatric surgeons in the operating theatre under general anesthesia. It is of note that all but 6 cases that had their FB extracted via rigid bronchoscopy underwent a diagnostic flexible bronchoscopy by a pediatric pulmonologist before the rigid bronchoscopy was undertaken for FB extraction. Post bronchoscopy complications were reported in only 2.6% cases, with no procedure related mortalities (Table [1](#Tab1){ref-type="table"}).

Of the 300 cases, 82 patients underwent multiple bronchoscopies. Twelve of these were patients who did not have a FB visualized during their initial procedure, but had a subsequent bronchoscopy performed a day or two later to exclude any missed FB as they remained symptomatic. The remaining 70 patients had a FB, but required multiple bronchoscopies due to various reasons. 45 patients had a flexible bronchoscopy performed for diagnostic purposes, and once the FB was located, a rigid bronchoscopy was done for FB extraction. In 8 patients, there was an unsuccessful attempt to extract the FB via flexible bronchoscopy, necessitating a second rigid bronchoscopy. In another 8 patients, the initial bronchoscopy (either rigid or flexible) extracted the FB incompletely; needing a second bronchoscopy for extracting the remnants. Nine patients were complicated cases who were admitted to the intensive care unit from the outset, they underwent multiple bronchoscopies including follow up bronchoscopies performed to rule out retained FB. One of these 9 patients eventually required a thoracotomy.

The most common site of FB lodging was the right main stem bronchus (47.3%), followed by the left bronchus (32, 35.2%), bilateral bronchi (5, 5.5%), carina (5, 5.5%) and the trachea (6, 6.6%). The rest were recovered from segmental smaller airways. Organic FB accounted for 62.6% of the FB removed, with peanuts (*n* = 15) being the most common type, followed by seeds (*n* = 13) and beans (*n* = 4), pistachios, and other food materials. Eight (8.8%) of the FB were inorganic; most of them were either metal or plastic objects, out of which 4, as stated earlier, were radio-opaque. In the remaining 28.6% cases, the patients' records did not specify the type of FB. Table [1](#Tab1){ref-type="table"} outlines the bronchoscopy findings.

Predictors associated with proven FBA and risk scoring system {#Sec12}
-------------------------------------------------------------

Historical, clinical, physical exam and radiological findings associated with FBA are shown in Table [2](#Tab2){ref-type="table"}. The derivation of the weighted risk score for FBA is shown in Table [3](#Tab3){ref-type="table"}. The five predictors selected for the risk score were history of witnessed choking (adjusted OR 2.1, 95% CI 1.1--4.3; *P* = 0.041), noisy breathing/stridor/ dysphonia (adjusted OR = 2.7, 95% CI 1.2--6.2; *P* = 0.015), new onset wheezing/ recurrent/persistent wheeze (adjusted OR 4.6, 95% CI 1.8--11.8; *P* = 0.002), abnormal chest x-ray findings (adjusted OR 4.0, 95% CI 1.9--8.5; *P* \< 0.001), and unilateral reduced air entry (adjusted OR 2.9, 95% CI 1.5--5.5; *P* = 0.001) were significant predictors associated with an increased risk for FBA (*P* \< 0.05). The clinical feature of witnessed choking on history was used as the reference regression coefficient and assigned a weighted value of 1. The discriminative ability of the model was found to be good with an area under the ROC curve value of 0.76 (95% CI 0.70, 0.82). The sensitivity and specificity values at a cutoff score point of ≥4 were 49 and 85%, and at a cutoff score point of ≥5 were 22 and 98% (positive likelihood ratio 6.6), respectively (Fig. [1](#Fig1){ref-type="fig"}). The predicted cutoff score derived using ROC analysis was found to co-relate well with known clinically significant predictors of FBA (Fig. [2](#Fig2){ref-type="fig"}).Fig. 1ROC curve using weighted risk score in predictive diagnosis of FBA Fig. 2Clinical algorithm with scoring system for children with suspected FBA

Based on the aforementioned results and statistically significant predictors associated with FBA derived from multivariate logistic regression, we designed a clinical algorithm with a scoring system. In our proposed algorithm, (Fig. [2](#Fig2){ref-type="fig"}), each of the significant FBA predictors namely witnessed choking, noisy breathing/stridor/dysphonia, new onset/recurrent/persistent wheeze, unilateral reduced air entry and abnormal CXR are assigned a weighted risk score of 1, 1, 2, 1 and 2 respectively. Patients with a score of 5 or more had nearly 72% bronchoscopy proven FBA. For a child with a score range of 4--5, our study demonstrated that 59% had bronchoscopy proven FBA. In patients with a score of 2--3, the bronchoscopy proven FBA was \~29.8%, while with a score of ≤1, the bronchoscopy proven FBA dropped to no more than 9.6%.

Patients were also grouped based on the cumulative presence of 4 of the above 5 mentioned FBA predictors (witnessed choking crisis, Noisy breathing/stridor/dysphonia, New onset wheezing/recurrent/persistent wheeze, and/or decreased air entry). Figure [3a](#Fig3){ref-type="fig"} shows the cumulative proportion of children with proven FBA according to these 4 risk factors. Only 7.7% of the children without any of these risk factors had a proven FBA. The likelihood increased significantly with an increasing number of risk factors. When all 4 risk factors were present, the likelihood of FBA was 100%. A total of 242 of these 300 patients were also analyzed and grouped based on whether they had normal or abnormal physical and/or radiological findings on presentation. The remainder of the patients did not have a documented exam and/or chest radiological findings on record review. The results were as follows: (Fig. [3b](#Fig3){ref-type="fig"}) in children with both abnormal physical and radiological findings, 47.2% had a proven FBA. If only one was abnormal (i.e. either physical exam or chest x-ray), the likelihood of FBA reduced to 32--33.3%. In children who presented with a completely normal physical exam and chest radiograph, only 7.4% had a FB removed by bronchoscopy (Fig. [3b](#Fig3){ref-type="fig"}).Fig. 3**a** Cumulative proportions of proven FBA by number of risk factors (witnessed choking crisis, noisy breathing/stridor/dysphonia, new onset wheezing/ recurrent/ persistent wheeze, and/or decreased air entry). Normal = patients with none of the above risk factors, Group 1 = patients with 1 risk factor, Group 2 = patients with any of the 2 above risk factors, Group 3 = patients with any of the 3 above risk factors and Group 4 = patient with all of the above risk factors. **b** Incidence of FBA found on bronchoscopy. Group categorizations: Group 1, children with abnormal physical and radiologic findings (*n* = 110); group 2, children with abnormal physical and normal radiologic findings (*n* = 30); group 3, children with normal physical and abnormal radiologic findings (*n* = 25); group 4, children with normal physical and radiological findings (*n* = 67). The sum is not equal 300 as in 58 cases either CXR was not done or not documented and therefore all the percentages were calculates based on 242 cases

Discussion {#Sec13}
==========

Children with suspected FBA will always present a perplexing diagnostic dilemma because the condition can only be established unequivocally after the patient has undergone a bronchoscopy \[[@CR11]\]. There is no global consensus regarding reliable indications for bronchoscopy in children with suspected FBA. This variation in practice is also reflected in the different rates of positive bronchoscopies, among different centers around the world. In our study, about one third of the patients (30.3%) who underwent bronchoscopy for suspected FBA had positive findings. In a similar study by Shlomo Cohen et al. \[[@CR5]\] the rate of positive bronchoscopies was 45%. Other studies from around the world quote positive bronchoscopy rates, which vary widely, ranging from as low as 25 to over 90% \[[@CR12]--[@CR16]\].

There is not only a significant discrepancy among institutions, regarding the management of these children, but frequently also among physicians working in the same center. The decision is often based wholly on the discretion of the treating physician. Many previous studies have attempted to establish the criteria for bronchoscopy in children with FBA by drawing conclusions from the presenting history, examination and chest radiograph findings of patients with bronchoscopically proven FBA \[[@CR2], [@CR5], [@CR17]--[@CR20]\].

In this study, we attempted to go a step further by utilizing the statistically significant predictors we identified based on cases with bronchoscopically proven FBA to formulate a clinical algorithm with a scoring system which would help to decide which sub set of patients who present with a history suggestive of FBA require a prompt bronchoscopy. Using multivariable logistic regression analysis controlling for all other potential predictors, we found that the predictors with the strongest association with FBA are witnessed choking crisis, noisy breathing/stridor/dysphonia, new onset, recurrent or persistent wheeze, abnormal chest x-ray findings, and unilateral reduced air entry (Tables [3](#Tab3){ref-type="table"} and [4](#Tab4){ref-type="table"}). No significant interactions were observed between the various other historical signs and symptoms, radiological and physical examination findings. The discriminative ability of the model was found to be good with an area under the ROC curve value of 0.76 (95% CI 0.70, 0.82). The predicted cutoff score derived using statistically significant predictors and ROC analysis was found to be almost similar to that derived from clinically significant predictors and supports the clinical algorithm and scoring shown in Fig. [2](#Fig2){ref-type="fig"}.

Figure [3a](#Fig3){ref-type="fig"} demonstrates the cumulative effect of 4 of the predictive risk factors (witnessed choking crisis, noisy breathing/stridor/dysphonia, new onset wheezing/ recurrent/persistent wheeze, and/or decreased air entry) derived from our study, with the probability of finding a FB increasing to 100% when all 4 risk factors were present. Heyer CM et al. \[[@CR21]\] reported cumulative proportions of children with proven FBA according to three risk factors, focal hyperinflation, witnessed choking crisis, and elevated white blood cell count and observed that sixteen percent of the children without any of these risk factors still had proven FBA, but the probability of proven FBA increased sharply with an increasing number of risk factors, just like in our study as seen in Fig. [3a](#Fig3){ref-type="fig"}.

It was noted that among patients who had both a pathological physical exam finding and an abnormal chest radiograph nearly half the cases (47.2%) had a FB on bronchoscopy. This is in contrast to children who presented with a completely normal physical exam and chest radiograph, where only 7.4% had evidence of FBA (Fig. [3b](#Fig3){ref-type="fig"}). Shlomo et al. had similar findings and concluded that patients with no physical or radiological abnormalities did not require a bronchoscopy as long as they were asymptomatic \[[@CR5]\].

Based on our novel algorithm (Fig. [2](#Fig2){ref-type="fig"}), patients with a score of 5 or more had nearly 72% bronchoscopy proven FBA. We recommend performing a prompt rigid bronchoscopy in these cases, as the risk of FBA is quite high \[[@CR5], [@CR17]\]. For a patient with a score range of 4--5, with 59% bronchoscopy proven FBA, we propose either a flexible or rigid bronchoscopy based on the availability of local protocols and expertise of individual centers. In patients with a score of 2--3, where the bronchoscopy proven FBA was \~29.8%, the procedure of choice would be a flexible bronchoscopy to avoid general anesthesia in the large number of patients who may not have a FB. When the score is less than or equal to 1 on our algorithm, patients can be safely followed-up on an outpatient basis as long as close monitoring is available since the bronchoscopy proven FBA was found to be just under 10%.

In our study, based on Fig. [2](#Fig2){ref-type="fig"}, there were 4 patients who were eventually diagnosed with a FB but did not fulfill the predictive criteria as per our algorithm, i.e. had a score of "0". Two of these four cases were toddlers who had chronic upper respiratory tract symptoms including persistent cough. Another presented with radiological evidence of right lower lobe bronchiectasis and the fourth with a unilateral foul smelling purulent nasal discharge with a FB extracted from the left nasal passage. In all except one of the aforementioned cases, the FB was successfully extracted via flexible bronchoscopy.

The major limitation of our study is that our data was collected and analyzed retrospectively and thus complete documentation regarding key clinical parameters such as history, CXR or physical exam findings were not available for all patients. On the other hand, the fact that this is a cohort data involving a large number of patients over a 10 year period makes this a valuable study.

Conclusions {#Sec14}
===========

Accurately diagnosing FBA in children who need quick intervention will always be challenging. A high index of suspicion is required, along with a comprehensive historical account, detailed physical exam and chest radiography. Our proposed clinical algorithm and scoring system hopes to empower physicians dealing with such cases to accurately predict patients with a high likelihood of FBA. Although, the ultimate decision for bronchoscopy may be eventually based on the physician's clinical judgment, having a reliable, statistically proven tool to base that decision on will be invaluable in initiating prompt management in those deemed high risk for FBA, as well as avoiding unnecessary intervention in those who have a very low probability of aspiration.
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